share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E

SEC announcement ·  May 8 06:36
Summary by Futu AI
On May 3, 2024, Susan E Quaggin, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. The transaction, which was completed on the same day, increased Quaggin's direct holdings in the company to a total of 1,322 shares. The shares granted are of $0.01 par value each, and the grant signifies a direct acquisition of equity in the pharmaceutical company.
On May 3, 2024, Susan E Quaggin, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. The transaction, which was completed on the same day, increased Quaggin's direct holdings in the company to a total of 1,322 shares. The shares granted are of $0.01 par value each, and the grant signifies a direct acquisition of equity in the pharmaceutical company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.